| Bioactivity | FR 78844 is a potent and orally active bone resorption inhibitor. FR 78844 has the potential for the research of diabetes associated osteopenia[1]. |
| In Vivo | FR 78844 (1, 10, 100 mg/kg; p.o.; 5 days a week for 4 weeks) 可减轻大鼠干骺端骨矿物质密度的下降[1]。 MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: |
| CAS | 112856-39-0 |
| Formula | C8H9NNa2O6P2S |
| Molar Mass | 355.15 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Takeshita N, et al. Possible involvement of vitamin D3-deficiency and relatively enhanced bone resorption in the development of bone loss in streptozotocin-induced diabetic rats. Life Sci. 1994;55(4):291-9. |
FR 78844
CAS: 112856-39-0 F: C8H9NNa2O6P2S W: 355.15
FR 78844 is a potent and orally active bone resorption inhibitor. FR 78844 has the potential for the research of diabete
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.